Antibodies: payments to doctors
Payments that named Antibodies as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Richard-allan Scientific Company?
Richard-allan Scientific Company reported the most payments naming Antibodies. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $19K
- Providers
- 0
- Transactions
- 8
- Average per transaction
- $2,363
The per-transaction average — $2,363 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Richard-allan Scientific Company | $18,905 | 100.0% |
Other products from Richard-allan Scientific Company
The company that reported the most payments naming Antibodies also reports against these.
- Health Hazard Assesments$17,033
- CryoStar NX50 Ser # S18061306$4,425
- Somatostatin Receptor$1,571
- Chromagranin A Ab-1$1,298
- HM325' Tome New6 Ser # S18010144$1,113